CoreAge Rx Introduces NAD+ Injectable Therapy to Support Cellular Energy, Cognitive Function, and Healthy Aging
Wichita Falls, TX, United States, 24th Apr 2026 – CoreAge Rx, a LegitScript-certified telehealth provider specializing in medically supervised weight management and wellness protocols, has announced the launch of its NAD+ (Nicotinamide Adenine Dinucleotide) Injectable, a new addition to its growing portfolio of therapies focused on cellular health, energy metabolism, and longevity support.
The NAD+ Injectable is introduced as part of CoreAge Rx’s broader “Brain + Body Energy Protocol,” offering patients a structured, physician-guided approach to supporting mitochondrial function, cognitive clarity, and metabolic efficiency. The therapy is administered via intramuscular or subcutaneous injection and is available through the company’s fully digital care platform.
Addressing Declining NAD+ Levels with Targeted Delivery
NAD+ is a coenzyme found in every cell of the body and plays a central role in energy production, DNA repair, and cellular maintenance. As individuals age, NAD+ levels naturally decline, which has been associated with reduced energy, cognitive changes, and metabolic inefficiencies.
CoreAge Rx’s injectable NAD+ formulation is designed to deliver the compound directly into the bloodstream, allowing for rapid absorption and systemic distribution. This delivery method is intended to support both neurological and physiological processes more efficiently compared to traditional oral supplementation.
By integrating NAD+ therapy into its telehealth model, CoreAge Rx enables patients to access physician-reviewed protocols without the need for in-person visits, while maintaining structured medical oversight throughout the process.
Key Features and Potential Benefits
According to CoreAge Rx, the NAD+ Injectable is formulated to support a range of wellness goals, including:
- Increased energy levels, stamina, and mental clarity
- Support for healthy aging and DNA repair processes
- Enhanced mitochondrial function and cellular resilience
- Neuroprotective support and cognitive performance
- Compatibility with lifestyle protocols such as exercise and fasting
- Fast-acting delivery with high bioavailability
The company notes that the therapy may also be used alongside other physician-guided protocols, depending on individual health goals and clinical recommendations.
Expanding Access Through a Digital-First Care Model
CoreAge Rx continues to emphasize accessibility and efficiency through its telehealth platform. Patients can complete consultations, receive physician evaluations, and begin treatment entirely online. This model is designed to reduce delays, eliminate traditional barriers to care, and provide a streamlined experience from onboarding to delivery.
The introduction of NAD+ Injectable reflects the company’s ongoing effort to expand beyond GLP-1–based metabolic care into broader wellness and longevity-focused therapies, while maintaining the same structured and physician-supervised approach.
Third-Party Evaluations Underscore CoreAge Rx’s Credibility
As the telehealth landscape continues to evolve, CoreAge Rx is being consistently recognized by independent evaluators for its structured care model, accessibility, and patient-focused delivery. These acknowledgments reflect a broader industry shift toward transparent, physician-guided digital healthcare.
IKAN Health on Accessibility and Patient Flow
IKAN Health’s editorial review pointed to CoreAge Rx’s ability to remove traditional barriers to care, particularly for patients without insurance. Its no-waitlist system and fully online process were noted as key elements that simplify and accelerate access to treatment.
Online Therapist AI’s 2026 Rankings
In its March 2026 evaluation, Online Therapist AI ranked CoreAge Rx as the top recommended GLP-1 provider, assigning it a 4.9 out of 5.0 rating. The platform’s affordability, clear pricing structure, and consistent clinical oversight were highlighted as major strengths.
Eventual Health Care’s 2026 Assessment
Eventual Health Care identified CoreAge Rx as the leading online provider for tirzepatide in 2026. The review emphasized the platform’s physician-supervised approach, transparent pricing model, and overall patient experience.
Taken together, these independent evaluations reinforce CoreAge Rx’s position within the telehealth sector, highlighting its alignment with emerging standards centered on accessibility, transparency, and medically guided care.
Customer Experience Reflects Consistency in Care and Support
Beyond industry recognition, CoreAge Rx has received positive feedback from patients highlighting the platform’s responsiveness, accessibility, and overall experience.
One reviewer shared that the company’s customer service team provided “fast and informative responses” to multiple questions, while also proactively communicating during a weather-related shipping delay. The reviewer noted that the product “helped in ways I didn’t know it could.”
Another patient described the process as smooth once initial concerns were addressed, stating that shipping was straightforward and the medication was “easy and helpful so far.”
A third review emphasized the support provided throughout the journey, noting that “the whole process from enrolling to shipping went smoothly,” and that physician access helped reassure patients during treatment.
These experiences reflect CoreAge Rx’s continued focus on combining clinical oversight with accessible, patient-centered support.
Conclusion
With the introduction of its NAD+ Injectable, CoreAge Rx continues to expand its physician-supervised telehealth offerings into the growing category of cellular health and longevity support. By combining a structured medical approach with a fully digital care pathway, the company aims to make advanced wellness protocols more accessible to individuals seeking support for energy, cognitive function, and overall metabolic health.
The launch reflects a broader shift toward personalized, convenience-driven care models, where patients can access clinically guided treatments without traditional barriers. As interest in mitochondrial health and aging-related interventions continues to rise, CoreAge Rx positions its NAD+ Injectable as part of an evolving approach to modern, medically supervised wellness.
To learn more about the NAD+ Injectable, visit: https://www.coreagerx.com/nad-injection/
Company Details
Organization: CoreAge Rx
Contact Person: Ella Jones
Website: https://www.coreagerx.com/
Email: Send Email
Contact Number: +19404004927
City: Wichita Falls
State: TX
Country: United States
Release Id: 24042644316